Skip to main content
. 2019 Sep 6;7:348. doi: 10.3389/fped.2019.00348

Table 3.

Review of the KCNQ2 gene mutations involving the pore region of the voltage-gated potassium channel subfamily Q member 2.

Nucleotide/protein changes Phenotype Inheritance Seizures onset Semiology of seizures EEG appearance at onset First brain MRI Medications trialed Drug control Outcome References
c.761_770del10insA in KCNQ2 gene + c.2687A>G (p.N821S) in KCNQ3 gene BFNC (patient, mother, sister), West syndrome (maternal aunt) c.761_770del10insA in KCNQ2 gene: maternally inherited; c.2687A>G in KCNQ3 gene: paternally inherited 3rd day C seizures, right head and eyes rotation, palpebral myoclonias, oro-alimentary automatisms, and cyanosis Fast polyspikes on the left centro-temporal areas with diffusion; normal organization background Normal PB PB SF. At 18 months of age normal neurological examination and psychomotor development (44)
c.766G>T p.G256W EE (45)
c.773A>G p.N258S BFNC (46)
c.775G>T p.D259Y BFNC Inherited 3rd day Eye rolling, joint stiffness, and upper limb clonus Normal Normal PB, VA PB, VA SF. Normal psychomotor development (34)
c.790T>A p.Y264N Seizures during neonatal period and infancy (47)
c.793G>A p.A265T EE De novo Before 2nd day T and/or C, T with apnea, ES, F hypermotor Bursts of asynchronous spikes and sharp waves, discontinuity/BS T1 hypersignal of the pallida, caudate nuclei, and hyppocampi; T2 hypersignal of the parietal occipital white matter/Normal PB, MDZ, LVT, PH, ZNS, VA, VGB, CLB, BTN, FLT, KD, TPM, B6, ACTH, EZO Improvement with EZO M jerks /ES/SF since early adolescence. Poor psychomotor development (27), (18), (42), (34)
c.793G>C p.A265P EE De novo 7th day T flexion spasms Multifocal epileptic activity Small frontal and temporal lobes, thin CC, hyper-T2, and hypo-T1 signals in cerebellum, frontal ventriculomegaly, increased frontotemporal extra-axial CSF spaces VGB, VA, TPM VGB temporary response SF since age 2 y 6 m. Poor psychomotor development (11)
c.794C>T p.A265V EE De novo 1st-5th day Apneic spells, T spasms with right opsoclonus-like movement, T seizures, left-sided seizures BS/ Multifocal sharp waves Mildly delayed myelination, T2 high signal on GP/Normal CBZ, DZP, MDZ, PB, PLP, VA, B6, ZNS, CLN, CLB, VGB DZP, MDZ, PB partially effective; CBZ effective Myoclonus at the bilateral upper extremities/SF/Intractable seizures. Poor psychomotor development (13), (12)
c.802C>T p.L268F EE De novo 1st day F seizures Multifocal epileptiform discharges Diffuse hypomielination with volumetric reduction of the frontal lobe PB, PH, LVT, TPM LEV+TPM Mild global impairment (24)
c.803T>C p.L268P EE (Ohtahara-type), multifocal epilepsy De novo <24 hrs of life T, TC, and F seizures BS Delayed myelination PB, LVT, PH, TPM, OXC, BTN, FLT OXC+TPM SF. Poor psychomotor delay (34)
p.W269L EE EZO Improvement with EZO (42)
c.807G>A p.W269Ter BFNC Inherited 3rd day F, initial T phase followed by asynchronous C phase Normal background with centrotemporal sharp waves CBZ CBZ SF. Normal psychomotor development (21)
c.807G>A p.W269X BFNC, febrile seizures, generalized epilepsy in adulthood (9)
c.811C>T p.A294V EE 1st day Discontinuity, asymmetric low voltage suppression, interictal epileptiform discharges, poorly organized background Small focus of reduced diffusion in the left posterior parietal white matter PB, LVT, B6, TPM, PH PB, LVT, TPM Reemergence of seizure activity upon attempt to wean AED (48)
c.812G>T p.G271V BFIC, choreoathetosis, myokymia (30)
c.821C>T p.T274M EE De novo 2nd-3rd day Stiffening, head, and eye deviation, T posturing, T and hypoT seizures, ES BS, hypsarrhythmia, right temporal asymptomatic seizures Hyperintensity of basal ganglia, irregular right thalamus, small frontal lobe, reduced white matter volume, thin CC, giant perivascular spaces/Normal LVT, PB, PH, CLN, VGB, GBP, TPM, PRD, VA, OXC, EZO, CLB OXC; some improvement with TPM; SF, reduced frequency of ES, increased alertness, and tone with EZO SF/ES. Poor psychomotor development (11), (27), (42), (34)
c.827C>T p.T276I EE (Ohtahara-type) De novo 1st day BS Reduced posterior white matter volume, thin CC Poor psychomotor development (49)
c.830C>T p.T277I EE De novo 2nd day T seizures, FC activity DNV Normal PB, MDZ, PN, LVT, LDN, CLN, TPM, VA LVT and LDN acutely effective, VA effective SF since 1.5m, one febrile seizure at 1y. Poor psychomotor development (23)
c.835G>T p.G279C EE Intellectual disability (50)
c.841G>A p.G281R EE De novo 2nd day T, T spasm-like, M, and hemiC seizures BS Atrophy of frontal lobe, thin CC, delayed myelination PB, VGB, VA, PH, TPM, LVT, LTG, KD, ZNS PB transient response, KD some response Daily M seizures, clusters of T seizures, poor psychomotor development (18)
c.841G>C p.G281R EE De novo 1st day T, C seizures BS Small thalami PB, KD, RTG, TPM, steroids, VGB, VA, LVT, LCM PB+KD+ high dose RTG (strong reduction in seizures); TPM and steroids some response Weekly T seizures. Poor psychomotor development (18)
c.841G>T p.G281W EE De novo 2nd day SE, T asymmetric seizures Multifocal epileptiform discharges Hyperintensity in the basal ganglia, thalami/hippocampus PB, LVT, CBZ CBZ Poor psychomotor delay (24)
c.847_848insGT p.K283SfsTer36 BFNC Inherited (5)
c.850T>C p.Y284H EE De novo <1 m of life F, M, G seizures; spasms SF. Poor psychomotor development (51)
c.850T>G p.Y284D EE De novo 48 hrs F seizures, startle episodes, ES, T seizures Hypsarrhythmia Cortical-subcortical atrophy with altered white matter, thin CC PB, PN, VA, VGB, ZNS, CLB, CBZ, LVT None ES, T seizures. Poor psychomotor development (34)
c.851A>G p.Y284C BFNC (5)
c.854C>A p.P285H OS Inherited (mother: idiopathic epilepsy since neonate, medicated with VA) 2nd day T seizures BS, asymmetric T1 and T2 high signal on GP VA, PLP, PB VA SF. Poor psychomotor development (12)
p.P285S OS De novo 1st day T, simple partial seizures BS Normal PB, TPM, VA None Refractory epilepsy (17)
c.860C>A p.T287N EE 1st day C, T seizures BS Normal PB, VGB SF. Poor psychomotor development (27)
c.868G>A p.G290S EE De novo 1st day T seizures BS, multifocal slow waves, frontal, and occipital spikes, generalized flattening Normal PB, VGB, CBZ, PH, LDN, CLN PH SF. Poor psychomotor development (12), (27)
c.869G>A p.G290D EE De novo 2nd day T; myoclonias of arms and eyelid, C movements BS/ Multifocal epileptic activity Thin CC/ Hyperintensity of basal ganglia PB, LVT, VA, CLN VA+CLN Monthly T or TC seizures, often with fever; SF since then. Poor psychomotor development (11)
c.875T>C p.L292P EE 1st day Discontinuity with epochs of complete suppression in either or both hemisphere and epileptiform discharges, poorly organized background Normal PB, LVT, TPM, CBZ CBZ, LVT At the 9 m follow-up visit the patient was meeting the developmental milestones. SF but difficulty in balancing seizure control with sedation and feeding (48)
c.881C>G p.A294G BFNC (52)
c.881C>T p.A294V Mostly EE; EIMFS evolving to IS Mostly de novo 10 h-14th day Excessive paroxysmal fetal movements; neonatal jitteriness; M, T, C, GTC seizures; spasms; SE; startle episodes BS; hypsarrhythmia, multifocal/bilateral discharges, attenuation, discontinuity, asynchrony, slow background activity Normal/ Increased signal over lentiform nuclei bilaterally/ T2 high signal on GP PB, LVT, MDZ, VA, PH, TPM, VGB, CLN, BTN, FLT, PDN, ACTH, B6, CBZ, ZNS, PLP, NZP PH (initial response), LVT (minimal response), ACTH (partially effective), VA, CBZ, ZNS, TPM SF/ Uncontrollable seizure. Poor psychomotor development (53), (12), (27), (54), (52), (24), (34), (28)

BFNS-causing mutations are often non-sense, whereas OS/EOEE-causing mutations are all missense, as previously described by Millichap et al. (42).

AED, anti-epileptic drugs; BFIC benign familial infantile convulsions; BFNC, benign familial neonatal convulsions; BS, burst suppression; BTN, biotin; B6, vitamin B6; C, clonic; CBZ, carbamazepine; CC, corpus callosum; CLB, clobazam; CLN, clonazepam; DNV, discontinuous normal voltage; DZP, diazepam; EE, epileptic encephalopathy; EIMFS, epilepsy of infancy with migrating focal seizures; ES, epileptic spasms; EZO, ezogabine; F, focal; FC, focal clonic; FLT, folate; G, generalized; GP, globus pallidus; GBP, gabapentin; hr, hour; IS, infantile spasms; KD, ketogenic diet; LCM, lacosamide; LDN, lidocaine; LTG, lamotrigine; LVT, levetiracetam; M, myoclonic; m month; MDZ, midazolam; NZP, nitrazepam; OS, Ohtahara syndrome; OXC, oxcarbazepine; PB, phenobarbital; PDN, prednisone; PH, phenytoin; PLP, pyridoxal 5' phosphate; PN, pyridoxine; RTG, retiagabine; SE, status epilepticus; SF, seizure-free; T, tonic; TC, tonic-clonic; TPM, topiramate; VA, valproic acid; VGB, vigabatrin; wks, weeks; y, year; ZNS, zonisamide.